Evaluation of adverse events in small‐breed dogs treated with maropitant and a single dose of doxorubicin
Abstract Background The recommended doxorubicin (DOX) dose for small dogs is 1 mg/kg. Recent data suggest that DOX‐induced gastrointestinal (GI) toxicosis can be reduced with maropitant treatment. Objectives To investigate the incidence of adverse events (AEs) in small‐breed dogs administered a sing...
Main Authors: | Fukiko Matsuyama, Kei Harada, Eri Fukazawa, Masanao Ichimata, Yuko Nakano, Tetsuya Kobayashi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-07-01
|
Series: | Journal of Veterinary Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1111/jvim.16439 |
Similar Items
-
Prognosis of primary pulmonary adenocarcinoma after surgical resection in small‐breed dogs: 52 cases (2005‐2021)
by: Masanao Ichimata, et al.
Published: (2023-07-01) -
Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study
by: Hannah Kenward, et al.
Published: (2017-08-01) -
Cardiorespiratory Effects and Desflurane Requirement in Dogs Undergoing Ovariectomy after Administration Maropitant or Methadone
by: Francesca Cubeddu, et al.
Published: (2023-07-01) -
Efficacy of Gabapentin versus Combination of Dexamethasone-Ondansetron in Prevention of Postoperative Nausea and Vomiting in Middle Ear Surgery: A Randomised Clinical Study
by: Usha R Sastry, et al.
Published: (2023-11-01) -
Comparison of P6 Acupoint Stimulation, Ondansetron and Dexamethasone for Prevention of Postoperative Nausea and Vomiting after Laparoscopic Surgeries: A Randomised Clinical Study
by: Krishnaraj Nivatha, et al.
Published: (2023-07-01)